|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/7088 | (2006.01) | ||
| A61K 31/713 | (2006.01) | ||
| A61P 3/00 | (2006.01) |
| (11) | Number of the document | 3052628 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14800179.5 |
| Date of filing the European patent application | 2014-10-03 | |
| (97) | Date of publication of the European application | 2016-08-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-26 |
| (46) | Date of publication of the claims translation | 2020-09-10 |
| (86) | Number | PCT/US2014/059160 |
| Date | 2014-10-03 |
| (87) | Number | WO 2015/051318 |
| Date | 2015-04-09 |
| (30) | Number | Date | Country code |
| 201361887288 P | 2013-10-04 | US | |
| 201461983720 P | 2014-04-24 | US |
| (72) |
BETTENCOURT, Brian, US
FITZGERALD, Kevin, US
QUERBES, William, US
DESNICK, Robert, J., US
YASUDA, Makiko, US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, Cambridge, MA 02142,
US
Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kompozicijos ir būdai ALAS1 geno raiškai nuslopinti |
| COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE |
| Payment date | Validity (years) | Amount | |
| 2025-09-16 | 12 | 289.00 EUR |
| 2026-10-03 |